Eukaryotic translation initiation factor 4 gamma 1 (EIF4G1)

The protein contains 1599 amino acids for an estimated molecular weight of 175491 Da.

 

Component of the protein complex eIF4F, which is involved in the recognition of the mRNA cap, ATP-dependent unwinding of 5'-terminal secondary structure and recruitment of mRNA to the ribosome. As a member of the eIF4F complex, required for endoplasmic reticulum stress-induced ATF4 mRNA translation (PubMed:29062139). (updated: April 22, 2020)

Protein identification was indicated in the following studies:

  1. Goodman and co-workers. (2013) The proteomics and interactomics of human erythrocytes. Exp Biol Med (Maywood) 238(5), 509-518.
  2. Lange and co-workers. (2014) Annotating N termini for the human proteome project: N termini and Nα-acetylation status differentiate stable cleaved protein species from degradation remnants in the human erythrocyte proteome. J Proteome Res. 13(4), 2028-2044.
  3. Hegedűs and co-workers. (2015) Inconsistencies in the red blood cell membrane proteome analysis: generation of a database for research and diagnostic applications. Database (Oxford) 1-8.
  4. Bryk and co-workers. (2017) Quantitative Analysis of Human Red Blood Cell Proteome. J Proteome Res. 16(8), 2752-2761.
  5. D'Alessandro and co-workers. (2017) Red blood cell proteomics update: is there more to discover? Blood Transfus. 15(2), 182-187.
  6. Chu and co-workers. (2018) Quantitative mass spectrometry of human reticulocytes reveal proteome-wide modifications during maturation. Br J Haematol. 180(1), 118-133.

Methods

The following articles were analysed to gather the proteome content of erythrocytes.

The gene or protein list provided in the studies were processed using the ID mapping API of Uniprot in September 2018. The number of proteins identified and mapped without ambiguity in these studies is indicated below.
Only Swiss-Prot entries (reviewed) were considered for protein evidence assignation.

PublicationIdentification 1Uniprot mapping 2Not mapped /
Obsolete
TrEMBLSwiss-Prot
Goodman (2013)2289 (gene list)227853205992269
Lange (2014)123412347281224
Hegedus (2015)2638262202352387
Wilson (2016)165815281702911068
d'Alessandro (2017)18261817201815
Bryk (2017)20902060101081942
Chu (2018)18531804553621387

1 as available in the article and/or in supplementary material
2 uniprot mapping returns all protein isoforms as one entry

The compilation of older studies can be retrieved from the Red Blood Cell Collection database.

The data and differentiation stages presented below come from the proteomic study and analysis performed by our partners of the GReX consortium, more details are available in their published work.

No sequence conservation computed yet.

Interpro domains
Total structural coverage: 37%
Model score: 30

(right-click above to access to more options from the contextual menu)

VariantDescription
dbSNP:rs113810947
dbSNP:rs13319149
dbSNP:rs16858632
dbSNP:rs2178403
PARK18
Found in patients with Parkinson disease
a colorectal cancer sample
dbSNP:rs62287499
dbSNP:rs111500185
Found in a patient with Parkinson disease
Found in a patient with Parkinson disease
PARK18
dbSNP:rs35629949
dbSNP:rs2230570
dbSNP:rs73053766
Found in a patient with Rett syndrome-like phenotype

Biological Process

Behavioral fear response GO Logo
Cap-dependent translational initiation GO Logo
Cellular macromolecule biosynthetic process GO Logo
Cellular protein metabolic process GO Logo
Cellular response to nutrient levels GO Logo
Cytokine-mediated signaling pathway GO Logo
Developmental process GO Logo
Energy homeostasis GO Logo
Gene expression GO Logo
Insulin receptor signaling pathway GO Logo
Lung development GO Logo
Mitochondrion organization GO Logo
Negative regulation of autophagy GO Logo
Negative regulation of neuron death GO Logo
Negative regulation of peptidyl-threonine phosphorylation GO Logo
Nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay GO Logo
Nuclear-transcribed mRNA catabolic process, nonsense-mediated decay GO Logo
Nuclear-transcribed mRNA poly(A) tail shortening GO Logo
Positive regulation of cell death GO Logo
Positive regulation of cell growth GO Logo
Positive regulation of cell population proliferation GO Logo
Positive regulation of cellular protein metabolic process GO Logo
Positive regulation of energy homeostasis GO Logo
Positive regulation of eukaryotic translation initiation factor 4F complex assembly GO Logo
Positive regulation of G1/S transition of mitotic cell cycle GO Logo
Positive regulation of miRNA mediated inhibition of translation GO Logo
Positive regulation of mRNA cap binding GO Logo
Positive regulation of neuron differentiation GO Logo
Positive regulation of peptidyl-serine phosphorylation GO Logo
Positive regulation of translation in response to endoplasmic reticulum stress GO Logo
Regulation of cellular response to stress GO Logo
Regulation of gene silencing by miRNA GO Logo
Regulation of mRNA stability GO Logo
Regulation of polysome binding GO Logo
Regulation of presynapse assembly GO Logo
Regulation of translational initiation GO Logo
Response to ethanol GO Logo
Translation GO Logo
Translational initiation GO Logo
Viral process GO Logo

The reference OMIM entry for this protein is 600495

Eukaryotic translation initiation factor 4-gamma, 1; eif4g1
Eukaryotic translation initiation factor 4g; eif4g
Eif4-gamma
Eif4gi

DESCRIPTION

All eukaryotic cellular messenger RNAs are posttranscriptionally modified by addition of an m(7)GTP moiety to the 5-prime terminus, referred to as a cap. Recognition of the cap structure and unwinding of mRNA secondary structure during the initiation phase of protein synthesis is catalyzed by initiation factors of the eIF4 group. eIF4E (133440) is a 25-kD cap-binding protein. eIF4A (see 602641) is a 46-kD polypeptide that possesses ATP-dependent RNA helicase activity and RNA-dependent ATPase activity. eIF4B (603928) is a 69-kD RNA-binding protein that enhances the activity of eIF4A. eIF4-gamma, also known as p220, is a 154-kD protein that forms various complexes with the other eIF4 polypeptides. The complex of eIF4A, eIF4E, and eIF4-gamma has been referred to as either eIF4F or eIF4. Collectively, these factors facilitate the recruitment of mRNA to the ribosome, which is the rate-limiting step for protein synthesis under normal conditions. eIF4-gamma is the target for proteolytic cleavage during picornavirus infection, an event that is thought to be responsible for the inhibition of host cellular mRNA translation (Yan and Rhoads, 1995).

CLONING

By screening a rabbit brain library with oligonucleotide probes based on the sequence of rabbit eIF4-gamma peptides, Yan et al. (1992) identified partial eIF4-gamma cDNAs. They used the rabbit cDNAs as probes and isolated human brain cDNAs encoding eIF4-gamma. The predicted human protein contains 1,396 amino acids. Western blot analysis of poliovirus-infected HeLa cell extracts revealed that eIF4-gamma has an apparent molecular mass of 200 to 220 kD and is cleaved by this picornavirus. Imataka and Sonenberg (1997) stated that the N-terminal region of eIF4G contains a binding site for eIF4E. They demonstrated that the central third of eIF4G contains an eIF3 (see 602039)-binding region and an eIF4A-binding domain. A second, separate eIF4A-binding site is present in the C-terminal third. Neither eIF4A-binding domain alone activates translation. In contrast to eIF4G, the eIF4G-related translation regulator p97 (602325) binds eIF4A only through its N-terminal domain, which is homologous to the central domain of eIF4G. Gradi et al. (1998) identified a second human eIF4G gene. They designated the original gene eIF4GI and the novel gene eIF4GII (EIF4G3; 603929). Imataka et al. (1998) found that the human eIF4GI protein contains an additional 156 N-terminal amino acids compared to the sequence published by Yan et al. (1992). They demonstrated that this N-terminal region binds poly(A)-binding protein (PABP; 604679).

GENE FUNCTION

Imataka et al. (1998) found that, in an in vitro translation system, an N-terminal fragment of eIF4GI that included the PABP-binding site inhibited poly(A)-dependent translation, but had no effect on translation of a deadenylated mRNA. Imataka et al. (1998) concluded that eIF4G probably functions in poly(A)-dependent translation in mammalian cells. Using coimmunoprecipitation experiments, Pyronnet et al. (1999) demonstrated that MNK1 (MKNK1; 606724) is associated with the eIF4F complex via an interaction with the C-terminal region of eIF4G. They hypothesized that eIF4G provides a docking site for Mnk1 to phosphorylate eIF4E. Cytokine and protooncogene mRNAs are rapidly degraded through AU-rich elements in the 3-prime untranslated region. Rapid decay involves AU-rich binding protein AUF1 (601324), which complexes with heat-shock proteins ... More on the omim web site

Subscribe to this protein entry history

April 25, 2020: Protein entry updated
Automatic update: Entry updated from uniprot information.

Feb. 23, 2019: Protein entry updated
Automatic update: model status changed

Feb. 2, 2018: Protein entry updated
Automatic update: Uniprot description updated

Dec. 19, 2017: Protein entry updated
Automatic update: Uniprot description updated

Nov. 23, 2017: Protein entry updated
Automatic update: Uniprot description updated

March 16, 2016: Protein entry updated
Automatic update: OMIM entry 600495 was added.